Literature DB >> 20375163

Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies.

Bing Li1, Kelly Stefano-Cole, David M Kuhrt, Shari N Gordon, James G Else, Joseph Mulenga, Susan Allen, Donald L Sodora, Guido Silvestri, Cynthia A Derdeyn.   

Abstract

Simian immunodeficiency virus (SIV) infection of natural-host species, such as sooty mangabeys (SMs), is characterized by a high level of viral replication and a low level of generalized immune activation, despite evidence of an adaptive immune response. Here the ability of SIV-infected SMs to mount neutralizing antibodies (Nab) against autologous virus was compared to that of human immunodeficiency virus type 1 (HIV-1) subtype C-infected subjects. While high levels of Nab were observed in HIV-1 infection, samples obtained at comparable time points from SM exhibited relatively low titers of autologous Nab. Nevertheless, SM plasma with higher Nab titers also contained elevated peripheral CD4(+) T-cell levels, suggesting a potential immunologic benefit for SMs. These data indicate that AIDS resistance in these primates is not due to high Nab titers and raise the possibility that low levels of Nab might be an inherent feature of natural-host SIV infections.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375163      PMCID: PMC2876631          DOI: 10.1128/JVI.00295-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Sexual behavior of HIV discordant couples after HIV counseling and testing.

Authors:  Susan Allen; Jareen Meinzen-Derr; Michele Kautzman; Isaac Zulu; Stanley Trask; Ulgen Fideli; Rosemary Musonda; Francis Kasolo; Feng Gao; Alan Haworth
Journal:  AIDS       Date:  2003-03-28       Impact factor: 4.177

Review 2.  AIDS as a zoonosis: scientific and public health implications.

Authors:  B H Hahn; G M Shaw; K M De Cock; P M Sharp
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

3.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

4.  Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques.

Authors:  Jacob D Estes; Shari N Gordon; Ming Zeng; Ann M Chahroudi; Richard M Dunham; Silvija I Staprans; Cavan S Reilly; Guido Silvestri; Ashley T Haase
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

5.  Appreciating HIV type 1 diversity: subtype differences in Env.

Authors:  Rebecca M Lynch; Tongye Shen; S Gnanakaran; Cynthia A Derdeyn
Journal:  AIDS Res Hum Retroviruses       Date:  2009-03       Impact factor: 2.205

Review 6.  Understanding the benign nature of SIV infection in natural hosts.

Authors:  Guido Silvestri; Mirko Paiardini; Ivona Pandrea; Michael M Lederman; Donald L Sodora
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

7.  Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.

Authors:  Wendy W Yeh; Pimkwan Jaru-Ampornpan; Daiva Nevidomskyte; Mohammed Asmal; Srinivas S Rao; Adam P Buzby; David C Montefiori; Bette T Korber; Norman L Letvin
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

8.  Human immunodeficiency virus type 2 (HIV-2)/HIV-1 envelope chimeras detect high titers of broadly reactive HIV-1 V3-specific antibodies in human plasma.

Authors:  Katie L Davis; Frederic Bibollet-Ruche; Hui Li; Julie M Decker; Olaf Kutsch; Lynn Morris; Aidy Salomon; Abraham Pinter; James A Hoxie; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  J Virol       Date:  2008-11-19       Impact factor: 5.103

9.  Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.

Authors:  Penny L Moore; Nthabeleng Ranchobe; Bronwen E Lambson; Elin S Gray; Eleanor Cave; Melissa-Rose Abrahams; Gama Bandawe; Koleka Mlisana; Salim S Abdool Karim; Carolyn Williamson; Lynn Morris
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

10.  Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways.

Authors:  Rong Rong; Bing Li; Rebecca M Lynch; Richard E Haaland; Megan K Murphy; Joseph Mulenga; Susan A Allen; Abraham Pinter; George M Shaw; Eric Hunter; James E Robinson; S Gnanakaran; Cynthia A Derdeyn
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more
  26 in total

Review 1.  Natural SIV hosts: showing AIDS the door.

Authors:  Ann Chahroudi; Steven E Bosinger; Thomas H Vanderford; Mirko Paiardini; Guido Silvestri
Journal:  Science       Date:  2012-03-09       Impact factor: 47.728

2.  Depletion of CD4⁺ T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques.

Authors:  Alexandra M Ortiz; Nichole R Klatt; Bing Li; Yanjie Yi; Brian Tabb; Xing Pei Hao; Lawrence Sternberg; Benton Lawson; Paul M Carnathan; Elizabeth M Cramer; Jessica C Engram; Dawn M Little; Elena Ryzhova; Francisco Gonzalez-Scarano; Mirko Paiardini; Aftab A Ansari; Sarah Ratcliffe; James G Else; Jason M Brenchley; Ronald G Collman; Jacob D Estes; Cynthia A Derdeyn; Guido Silvestri
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 3.  Nonpathogenic simian immunodeficiency virus infections.

Authors:  Nichole R Klatt; Guido Silvestri; Vanessa Hirsch
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 4.  Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Authors:  Vasudha Sundaravaradan; Kiran D Mir; Donald L Sodora
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

5.  Distinct evolutionary pressures underlie diversity in simian immunodeficiency virus and human immunodeficiency virus lineages.

Authors:  Will Fischer; Cristian Apetrei; Mario L Santiago; Yingying Li; Rajeev Gautam; Ivona Pandrea; George M Shaw; Beatrice H Hahn; Norman L Letvin; Gary J Nabel; Bette T Korber
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

6.  Dualtropic CXCR6/CCR5 Simian Immunodeficiency Virus (SIV) Infection of Sooty Mangabey Primary Lymphocytes: Distinct Coreceptor Use in Natural versus Pathogenic Hosts of SIV.

Authors:  Sarah T C Elliott; Katherine S Wetzel; Nicholas Francella; Steven Bryan; Dino C Romero; Nadeene E Riddick; Farida Shaheen; Thomas Vanderford; Cynthia A Derdeyn; Guido Silvestri; Mirko Paiardini; Ronald G Collman
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

7.  Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome.

Authors:  Christian Selinger; Natasa Strbo; Louis Gonzalez; Lauri Aicher; Jeffrey M Weiss; G Lynn Law; Robert E Palermo; Monica Vaccari; Genoveffa Franchini; Eckhard R Podack; Michael G Katze
Journal:  Clin Vaccine Immunol       Date:  2014-10-01

8.  Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.

Authors:  Derseree Archary; Rong Rong; Michelle L Gordon; Saikat Boliar; Maphuti Madiga; Elin S Gray; Anne-Sophie Dugast; Tandile Hermanus; Philip J R Goulder; Hoosen M Coovadia; Lise Werner; Lynn Morris; Galit Alter; Cynthia A Derdeyn; Thumbi Ndung'u
Journal:  Virology       Date:  2012-09-18       Impact factor: 3.616

9.  Rapid Development of gp120-Focused Neutralizing B Cell Responses during Acute Simian Immunodeficiency Virus Infection of African Green Monkeys.

Authors:  Joshua D Amos; Jonathon E Himes; Lawrence Armand; Thaddeus C Gurley; David R Martinez; Lisa Colvin; Krista Beck; R Glenn Overman; Hua-Xin Liao; M Anthony Moody; Sallie R Permar
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

Review 10.  HIV-associated chronic immune activation.

Authors:  Mirko Paiardini; Michaela Müller-Trutwin
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.